Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-247.41M
Depreciation & Amortization
1.44M
Stock-Based Compensation
n/a
Other Working Capital
-17.18M
Other Non-Cash Items
92.39M
Deferred Income Tax
n/a
Change in Working Capital
-25.86M
Operating Cash Flow
-167.49M
Capital Expenditures
-855K
Cash Acquisitions
n/a
Purchase of Investments
n/a
Sales Maturities Of Investments
n/a
Other Investing Acitivies
n/a
Investing Cash Flow
-855K
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
166.83M
Financial Cash Flow
166.83M
Net Cash Flow
-3.68M
Free Cash Flow
-168.34M